CFO Kirk buys 12,000 ONCY shares at $0.84; 8 other insiders also bought within 14 days—cluster pattern
Look Kirk, CFO of Oncolytics Biotech, purchased 12,000 shares at $0.84 on 2026-02-12, increasing his holdings from 275,515 to 287,515 shares. This transaction occurs within a broader cluster of insider buying activity: 8 other insiders also purchased shares within the past 14 days. Such coordinated buying by multiple company officers typically reflects management's assessment of current valuation relative to company fundamentals and forward prospects. The stock is currently trading at $1.06, approximately 25.4% below its 52-week high of $1.42, and has been relatively flat over 30 and 90 days (up 1.0% and 1.9% respectively), suggesting the purchases may occur during a period of near-term price consolidation.